Get your score
Does BPC-157 heal injuries?
Healing results come almost entirely from animal studies; there are no proper human trials, and safety is unknown.
What you hear: “Injecting the peptide BPC-157 makes injuries like torn tendons heal dramatically faster.”
What the studies found
A 2025 systematic review found 36 relevant studies: 35 in animals or cells and just 1 in people. In animals, BPC-157 improved healing of muscle, tendon, ligament and bone injuries. The single human study was a look-back report in which 7 of 12 people injected in the knee for chronic knee pain said they had relief for more than 6 months, with no comparison group. Another review counted only three small human pilot studies in total and called it investigational. The FDA says it lacks enough information to know whether BPC-157 causes harm in people; in July 2026 an FDA advisory panel recommended allowing it in pharmacy compounding, but that advice is non-binding and is not a drug approval.
Take care: It is not an approved drug; products sold online are unregulated, and the FDA flags possible immune reactions and impurity problems. It is banned in sport at all times.
What you could do
For an injury, stick with proven care such as rest, physiotherapy and gradual loading, and treat BPC-157 as experimental.
Get your longevity score and see which everyday habits make the biggest difference for you.
Not medical advice. General information from published studies, not a diagnosis or a treatment plan. Talk with your doctor before starting a supplement or changing a medicine, especially if you are pregnant, take other medicines or have a health condition.
How we judged it
Not proven: Not enough good human evidence yet, either way. We judge the claim as it is usually said online, not the habit itself. Trials assign people at random, so they can show cause; observed studies follow people and show a link, not proof. Last checked: October 2026.
The studies, in their own words
- Vasireddi et al. HSS J 2025
After duplicates were removed, 36 studies were included (35 preclinical studies, 1 clinical study).
- Vasireddi et al. HSS J 2025
In a retrospective study of musculoskeletal pain following intraarticular injection of BPC-157 for unspecified chronic knee pain, 7 of 12 patients reported relief for >6 months.
- McGuire et al. Curr Rev Musculoskelet Med 2025
Until well-designed clinical trials are conducted, BPC-157 should be considered investigational, and its use approached with caution.
- American Med Spa Association: FDA advisory committee recommends adding BPC-157 to compounding list
The committee's recommendation is advisory.
- US FDA: Safety risks of certain bulk drug substances for compounding
Therefore, the agency lacks sufficient information to know whether the drug would cause harm when administered to humans.
- German Sport University Cologne: WADA class S0
This class covers many different substances, including but not limited to BPC-157, 2,4-dinitrophenol (DNP),
More claims, checked
- Not provenMetformin as an anti-aging pill
- Not provenCarnivore diet
- Not provenGlucose monitor without diabetes
- Doesn't hold upSeed oils are toxic
- Doesn't hold upRaw milk
- Doesn't hold upAlkaline water and alkaline diet
One short email when we add new studies or exercises, each with its source. No spam, and you can unsubscribe any time.